256 related articles for article (PubMed ID: 7748050)
1. Mycobacterium tuberculosis infection in pregnant and nonpregnant women infected with HIV in the Women and Infants Transmission Study.
Mofenson LM; Rodriguez EM; Hershow R; Fox HE; Landesman S; Tuomala R; Diaz C; Daniels E; Brambilla D
Arch Intern Med; 1995 May; 155(10):1066-72. PubMed ID: 7748050
[TBL] [Abstract][Full Text] [Related]
2. Utility of tuberculin and anergy skin testing in predicting tuberculosis infection in human immunodeficiency virus-infected persons in Thailand.
Yanai H; Uthaivoravit W; Mastro TD; Limpakarnjanarat K; Sawanpanyalert P; Morrow RH; Nieburg P
Int J Tuberc Lung Dis; 1997 Oct; 1(5):427-34. PubMed ID: 9441097
[TBL] [Abstract][Full Text] [Related]
3. Anergy during pregnancy.
Jackson TD; Murtha AP
Am J Obstet Gynecol; 2001 May; 184(6):1090-2. PubMed ID: 11349166
[TBL] [Abstract][Full Text] [Related]
4. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
Caiaffa WT; Graham NM; Galai N; Rizzo RT; Nelson KE; Vlahov D
Arch Intern Med; 1995 Oct; 155(19):2111-7. PubMed ID: 7575072
[TBL] [Abstract][Full Text] [Related]
5. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005.
Gupta A; Nayak U; Ram M; Bhosale R; Patil S; Basavraj A; Kakrani A; Philip S; Desai D; Sastry J; Bollinger RC;
Clin Infect Dis; 2007 Jul; 45(2):241-9. PubMed ID: 17578786
[TBL] [Abstract][Full Text] [Related]
6. The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research.
Klein RS; Flanigan T; Schuman P; Smith D; Vlahov D
Int J Tuberc Lung Dis; 1999 Aug; 3(8):681-8. PubMed ID: 10460100
[TBL] [Abstract][Full Text] [Related]
7. HIV infection and zidovudine use in childbearing women.
Sia J; Paul S; Martin RM; Cross H
Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis skin testing among HIV-infected pregnant women in Miami, 1995 to 1996.
Schulte JM; Bryan P; Dodds S; Potter M; Onorato IM; O'Sullivan MJ
J Perinatol; 2002 Mar; 22(2):159-62. PubMed ID: 11896523
[TBL] [Abstract][Full Text] [Related]
9. Lack of direct correlation between CD4 T-lymphocyte counts and induration sizes of the tuberculin skin test in human immunodeficiency virus type 1 seropositive patients.
Diagbouga S; Fumoux F; Ledru E; Sanou PT; Barro D; Marchal G
Int J Tuberc Lung Dis; 1998 Apr; 2(4):317-23. PubMed ID: 9559403
[TBL] [Abstract][Full Text] [Related]
10. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.
Elzi L; Schlegel M; Weber R; Hirschel B; Cavassini M; Schmid P; Bernasconi E; Rickenbach M; Furrer H;
Clin Infect Dis; 2007 Jan; 44(1):94-102. PubMed ID: 17143823
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for transmission of Mycobacterium tuberculosis from HIV-infected tuberculosis patients, Botswana.
Kenyon TA; Creek T; Laserson K; Makhoa M; Chimidza N; Mwasekaga M; Tappero J; Lockman S; Moeti T; Binkin N
Int J Tuberc Lung Dis; 2002 Oct; 6(10):843-50. PubMed ID: 12365569
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of hepatitis B and C in pregnant women who are infected with human immunodeficiency virus.
Santiago-Munoz P; Roberts S; Sheffield J; McElwee B; Wendel GD
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1270-3. PubMed ID: 16157150
[TBL] [Abstract][Full Text] [Related]
13. Trends in HIV-1 and HIV-2 prevalence and risk factors in pregnant women in Harare, Zimbabwe.
Mbizvo MT; Mashu A; Chipato T; Makura E; Bopoto R; Fottrell PF
Cent Afr J Med; 1996 Jan; 42(1):14-21. PubMed ID: 8868380
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium tuberculosis infection among crack and injection drug users in San Juan, Puerto Rico.
Reyes JC; Robles RR; Colón HM; Marrero CA; Castillo X; Meléndez M
P R Health Sci J; 1996 Sep; 15(3):233-6. PubMed ID: 8994290
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis skin testing in pregnancy: trends in a population.
Nolan TE; Espinosa TL; Pastorek JG
J Perinatol; 1997; 17(3):199-201. PubMed ID: 9210074
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
Sterling TR; Brehm WT; Moore RD; Chaisson RE
Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous anergy in pregnant and nonpregnant women with human immunodeficiency virus.
Eriksen NL; Helfgott AW
Infect Dis Obstet Gynecol; 1998; 6(1):13-7. PubMed ID: 9678142
[TBL] [Abstract][Full Text] [Related]
18. The incidence of tuberculosis in drug users with small tuberculin reaction sizes.
Klein RS; Gourevitch MN; Teeter R; Schoenbaum EE
Int J Tuberc Lung Dis; 2001 Aug; 5(8):707-11. PubMed ID: 11495260
[TBL] [Abstract][Full Text] [Related]
19. [HIV infection, tuberculosis and tuberculin test in Switzerland. The Swiss HIV Cohort Study].
Sudre P; Rieder H; Bassetti S; Hirschel BJ; Ledergerber B; Malvy D
Schweiz Med Wochenschr; 1996 Nov; 126(47):2007-12. PubMed ID: 8984608
[TBL] [Abstract][Full Text] [Related]
20. Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1997 Sep; 46(RR-15):1-10. PubMed ID: 9332982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
